Germany· DE-A57-4fc332afe982aeb3
Candesartan/Amlodipin Hexal
A medicinal product containing amlodipine besilate, candesartan cilexetil, registered in Germany by Hexal Ag.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Amlodipine Besilate, Candesartan Cilexetil
- Manufacturer
- Hexal Ag
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amlodipine besilate, candesartan cilexetil in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBILAMCARSwyssi AG, Frankfurt am Main
- ItalyCANDESARTAN E AMLODIPINA DOCDOC GENERICI S.R.L.
- FinlandAltensilLusomedicamenta Sociedade Técnica Farmacêutica SA
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Candam, Candeblo Amlo
- Belgium · Candesartan/Amlodipine Krka
- Bulgaria · Bilamcar 16 Mg/10, Bilamcar 8 Mg/10 Mg
- Czechia · Bilamcar, Camdero
- Estonia · Camdero, Zenicamo
- Spain · Kandoset
- Finland · Candecam
- France · Ikpara
- United Kingdom (Northern Ireland) · Candesartan Cilexetil/Amlodipine Zentiva
- Greece · Bilamcar, Caramlo
- Hungary · Kandoset
- Italy · Candesartan E Amlodipina, Candesartan E Amlodipina Doc
- Latvia · Camlocor, Zenicamo
- Malta · Clodipan
- Poland · Camlocor, Candezek Combi
- Portugal · Altensil, Amlodipina + Candesartan Krka
- Romania · Caramlo, Kandoset
- Slovenia · Amcandin, Camlocor
- Slovakia · Bilamcar 16 Mg/10 Mg, Bilamcar 16 Mg/5 Mg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7b69a7d-8852-4ad5-9a3e-a1e149708e5b GET /v1/drugs/f7b69a7d-8852-4ad5-9a3e-a1e149708e5b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Amlodipine Besilate, Candesartan Cilexetil",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about amlodipine besilate, candesartan cilexetil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.